Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
NCT05532813
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
142
Enrollment
OTHER
Sponsor class
Conditions
Steinert's Disease
Myotonic Dystrophy 1
Metformin
Interventions
DRUG:
Treatment taken
Sponsor
Assistance Publique - Hôpitaux de Paris